New drug reduces knee pain and weight in trials
Two trials involving over one thousand adults support experimental drug retatrutide for weight loss and knee osteoarthritis relief.
People taking high doses of the injectable lost an average of 25% of their body weight during the studies. Across both research projects, roughly two thirds of those receiving the active treatment reported at least a 50% drop in knee pain.
Those receiving the placebo reported a 38% reduction in osteoarthritis pain according to self reports from the participants. Retatrutide acts as a triple hormone receptor agonist which is only approved for compassionate use by the US Food and Drug Administration.
The drug also lowered blood pressure and inflammation levels in patients who took it as a once weekly injection. Dr Thomas Schnitzer said losing significant weight loads knees less which allows people to increase their daily function.
Some questions remain about whether non overweight individuals can benefit from pain relief aspects when treating knee osteoarthritis conditions. Scientists admit the mechanism is not entirely known and more research is needed to understand the condition better.

